GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we approach type 2 diabetes . These injectable therapies function to mimicking the body’s inherent https://bookmarksden.com/story21925928/glp-1-a-significant-advance-in-glucose-treatment